Financial Disclosure Statement

Kevin Meyer
Perfinity Biosciences

MSACL 2015 US Abstract Title:
Optimizing Trypsin Digestion

DescriptionY/NSource
Grantsno
SalaryyesPerfinity Biosciences
Board Memberno
Stockno
Expensesno

IP Royalty: no

Planning to mention or discuss specific products or technology of the company(ies) listed above:

yes